Document is current
Any future updates will be listed below
-
Authors
Mølgaard, Asger K.
Gasbjerg, Kasper S.
Mathiesen, Ole
Hägi-Pedersen, Daniel
Gögenur, Ismail
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 10 March 2025
First Online: 21 March 2025
Declarations
:
: The study was conducted on material from a biobank for future research collected at a selected site in the multi-center, randomized, blinded, placebo-controlled DEX-2-TKA Trial after signed informed consent (ClinicalTrials: NCT03506789, 24/04/2018; Ethics Committee in Region Zealand, Denmark identifier: SJ-695; EudraCT-number 2018–001099, 08/06/2018 with amendments on 30/08/2018 and 21/9/2018). The study was approved by the Ethics Committee in Region Zealand, Denmark (SJ-887, 21/12/2020 with amendment 21/09/2022) and the Danish Data Protection Agency (REG-174–2020, 21/01/2021 with amendment 16/01/2023). Due to the retrospective nature of the study and the analyses were describing a physiological process without potential to either identify specific patients or future or current, grave disease, a renewed informed consent was waived off.
: Consent for publication was covered by Regional Ethics Committee approval of the study.
: The authors declare no competing interests.
